Tepezza is an intravenous prescription medication that was that was approved by the U.S. Food & Drug Administration (FDA) in January 2020 for treatment of Thyroid Eye Disease (TED) which is a condition that is associated with Graves’ disease. During this illness, the eyeballs could bulge. double-vision could occur, and the tissue behind the eyes […]